Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
1.
Br J Nutr ; 111(11): 1957-66, 2014 Jun 14.
Artículo en Inglés | MEDLINE | ID: mdl-24576393

RESUMEN

Some lactic acid bacteria play an important role in the immune system with potential benefits to the host. However, detailed mechanisms of immune modulation exerted by probiotics remain to be clarified. Since immune response changes in a time-related manner in some cases, we monitored changes in mRNA levels in the spleen of mice during 14 d feeding with Lactobacillus brevis KB290 (KB290). Female BALB/c mice, aged 9 weeks, commenced a diet containing KB290 (3 × 109 colony-forming units/g) or starch for a period of 1, 4, 7 or 14 d. Cytotoxic activity of the resulting splenocytes against YAC-1 cells was measured using flow cytometry. The activity was found to be significantly higher in the treated group on days 1 and 7. The highest activity appeared on day 4, but was not statistically significantly different. Gene expression profiles were analysed using DNA microarray. Gene Ontology (GO) terms related to the immune process were significantly enriched in the up-regulated gene set on days 1, 4 and 7, and GO terms related to the cellular process were enriched in the down-regulated gene set on days 4 and 7. Although the up-regulated genes involved in antigen processing and presentation for stimulation of CD8+ cytotoxic T cells were not observed on day 14, some genes involved in T-cell and natural killer cell activation remained up-regulated until day 14. For the majority of the genes tested, RT-PCR analysis was used to verify the results obtained from the DNA microarray analysis. The sequential gene expression profiling reflected changes in cytotoxic activity during KB290 feeding.


Asunto(s)
Perfilación de la Expresión Génica , Levilactobacillus brevis , Probióticos/administración & dosificación , Bazo/metabolismo , Animales , Recuento de Colonia Microbiana , Regulación hacia Abajo , Femenino , Citometría de Flujo , Activación de Linfocitos , Ratones , Ratones Endogámicos BALB C , Análisis por Micromatrices , Linfocitos T Citotóxicos/metabolismo , Regulación hacia Arriba
2.
Can J Microbiol ; 60(3): 139-45, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24588387

RESUMEN

Cell-bound exopolysaccharide (EPS) of the aggregable strain Lactobacillus brevis KB290 isolated from traditional Japanese pickles has been reported to protect against the effects of bile. However, there are no reports of bile tolerance mechanisms for other L. brevis strains that have aggregability. To elucidate the mechanism of bile tolerance of L. brevis KB290, we found 8 aggregable L. brevis strains out of 121 L. brevis strains isolated from traditional Japanese fermented pickles. We estimated their growth in artificial digestive juice and the amount of cell-bound EPS. We found 3 types of aggregation for these strains: filiform (<1 mm), medium floc (1-5 mm), or large floc (>5 mm). There was no significant difference in growth between nonaggregable and aggregable strains in the artificial digestive juice. The large floc strains selected from the aggregation strains showed significantly higher growth in the artificial digestive juice than nonaggregable strains. In medium and large floc strains, cell-bound EPS, mainly consisting of glucose, N-acetylglucosamine, and N-acetylmannosamine, were observed. The amount of EPS and each strain's growth index showed a positive correlation. We conclude that aggregable L. brevis strains were also protected by cell-bound EPS.


Asunto(s)
Ácidos y Sales Biliares/metabolismo , Jugo Gástrico/metabolismo , Secreciones Intestinales/metabolismo , Levilactobacillus brevis/crecimiento & desarrollo , Polisacáridos Bacterianos/metabolismo , Verduras/microbiología , Acetilglucosamina/metabolismo , Bilis/metabolismo , Ácidos y Sales Biliares/farmacología , Fermentación , Glucosa/metabolismo , Hexosaminas/metabolismo , Humanos , Levilactobacillus brevis/efectos de los fármacos
3.
Can J Microbiol ; 60(4): 183-91, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-24693976

RESUMEN

Bile tolerance is a fundamental ability of probiotic bacteria. We examined this property in 56 Lactobacillus brevis strains isolated from Japanese pickles and also evaluated cellular fatty acid composition and cell-bound exopolysaccharide (EPS-b) production. The bile tolerance of these strains was significantly lower in modified de Man - Rogosa - Sharpe (MRS) medium (without Tween 80 or sodium acetate) than in standard MRS medium. Aggregating strains showed significantly higher bile tolerance than nonaggregating strains in MRS medium, but there was no significant difference in the modified MRS media. The relative octadecenoic acid (C18:1) content of the 3 most tolerant aggregating and nonaggregating strains was significantly higher when bile was added to MRS. In MRS without Tween 80, the relative C18:1 content was only marginally affected by addition of bile. In MRS without sodium acetate, only the 3 most tolerant nonaggregating strains increased their relative C18:1 content in the presence of bile. Meanwhile, culture in MRS without sodium acetate reduced EPS-b production in aggregating strains. In conclusion, both EPS-b and cellular fatty acid composition play important roles in bile tolerance of pickle-derived L. brevis.


Asunto(s)
Bilis/metabolismo , Cucumis sativus/microbiología , Ácidos Grasos/análisis , Levilactobacillus brevis/química , Polisacáridos Bacterianos/aislamiento & purificación , Medios de Cultivo/química , Ácidos Grasos/aislamiento & purificación , Heces/microbiología , Fermentación , Microbiología de Alimentos , Humanos , Japón , Levilactobacillus brevis/efectos de los fármacos , Levilactobacillus brevis/aislamiento & purificación , Polisacáridos Bacterianos/química , Probióticos
4.
Br J Nutr ; 110(9): 1617-29, 2013 Nov 14.
Artículo en Inglés | MEDLINE | ID: mdl-23544404

RESUMEN

Lactic acid bacteria confer a variety of health benefits. Here, we investigate the mechanisms by which Lactobacillus brevis KB290 (KB290) enhances cell-mediated cytotoxic activity. Female BALB/c mice aged 9 weeks were fed a diet containing KB290 (3 × 10(9) colony-forming units/g) or starch for 1 d. The resulting cytotoxic activity of splenocytes against YAC-1 cells was measured using flow cytometry and analysed for gene expression using DNA microarray technology. KB290 enhanced the cell-mediated cytotoxic activity of splenocytes. DNA microarray analysis identified 327 up-regulated and 347 down-regulated genes that characterised the KB290 diet group. The up-regulated genes were significantly enriched in Gene Ontology terms related to immunity, and, especially, a positive regulation of T-cell-mediated cytotoxicity existed among these terms. Almost all the genes included in the term encoded major histocompatibility complex (MHC) class I molecules involved in the presentation of antigen to CD8(+) cytotoxic T cells. Marco and Signr1 specific to marginal zone macrophages (MZM), antigen-presenting cells, were also up-regulated. Flow cytometric analysis confirmed that the proportion of MZM was significantly increased by KB290 ingestion. Additionally, the over-represented Kyoto Encyclopedia of Genes and Genomes pathways among the up-regulated genes were those for natural killer (NK) cell-mediated cytotoxicity and antigen processing and presentation. The results for the selected genes associated with NK cells and CD8(+) cytotoxic T cells were confirmed by quantitative RT-PCR. These results suggest that enhanced cytotoxic activity could be caused by the activation of NK cells and/or of CD8(+) cytotoxic T cells stimulated via MHC class I presentation.


Asunto(s)
Linfocitos T CD8-positivos/metabolismo , Citotoxicidad Inmunológica , Antígenos de Histocompatibilidad Clase I/metabolismo , Levilactobacillus brevis/inmunología , Linfoma/inmunología , Bazo/inmunología , Linfocitos T Citotóxicos/metabolismo , Animales , Células Presentadoras de Antígenos/metabolismo , Moléculas de Adhesión Celular/metabolismo , Línea Celular Tumoral , Femenino , Citometría de Flujo , Expresión Génica , Antígenos de Histocompatibilidad Clase I/genética , Células Asesinas Naturales/metabolismo , Lectinas Tipo C/metabolismo , Macrófagos/metabolismo , Ratones , Ratones Endogámicos BALB C , Análisis por Micromatrices , Receptores de Superficie Celular/metabolismo , Receptores Inmunológicos/metabolismo , Bazo/citología , Regulación hacia Arriba
5.
Can J Microbiol ; 59(8): 549-55, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23898998

RESUMEN

We examined the survivability of Lactobacillus brevis KB290 and derivative strain KB392 in artificial digestive juices and bile salts. The strains have similar membrane fatty acids but different amounts of cell-bound exopolysaccharides (EPS). In artificial digestive juices, KB290 showed significantly higher survivability than KB392, and homogenization, which reduced the amount of EPS in KB290 but not in KB392, reduced the survivability only of KB290. In bile salts, KB290 showed significantly higher survivability than KB392, and cell-bound EPS extraction with EDTA reduced the survivability of only KB290. Transmission electron microscopy showed there to be a greater concentration of cell-bound EPS in KB290 than in either KB392 or EDTA-treated or homogenized KB290. We conclude that KB290's cell-bound EPS (which high performance liquid chromatography showed to be made up of glucose and N-acetylglucosamine) played an important role in bile salt tolerance.


Asunto(s)
Levilactobacillus brevis/fisiología , Lípidos de la Membrana/química , Monosacáridos/análisis , Polisacáridos Bacterianos/química , Polisacáridos Bacterianos/metabolismo , Ácidos y Sales Biliares/farmacología , Quelantes/farmacología , Ácido Edético/farmacología , Jugo Gástrico/microbiología , Levilactobacillus brevis/química , Levilactobacillus brevis/efectos de los fármacos , Levilactobacillus brevis/metabolismo , Viabilidad Microbiana/efectos de los fármacos
6.
Curr Microbiol ; 65(6): 679-85, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-22936499

RESUMEN

Unlike dairy lactic acid bacteria, Lactobacillus brevis cannot ferment milk. We characterized the lactose utilization by L. brevis KB290. In a carbohydrate fermentation assay using API 50 CHL, we showed during 7 days L. brevis did not ferment lactose. L. brevis grew to the stationary phase in 2 weeks in MRS broth containing lactose as the carbon source. L. brevis slowly consumed the lactose in the medium. L. brevis hydrolyzed lactose and a lactose analog, o-nitrophenyl-ß-D-galactopyranoside (ONPGal). This ß-galactosidase activity for ONPGal was not repressed by glucose, galactose, fructose, xylose, or maltose showing the microorganism may not have carbon catabolite repression. We purified the L. brevis ß-galactosidase using ammonium sulfate precipitation and several chromatographies. The enzyme's molecular weight is estimated at 72 and 37 kDa using SDS-PAGE analysis. The N-terminal amino acid sequence of the larger protein was 90 % similar to the sequence of the putative ß-galactosidase (YP_796339) and the smaller protein was identical to the sequence of the putative ß-galactosidase (YP_796338) in L. brevis ATCC367. This suggests the enzyme is a heterodimeric ß-galactosidase. The specific activity of the purified enzyme for lactose is 55 U/mg. We speculate inhibition of lactose transport delays the lactose utilization in L. brevis KB290.


Asunto(s)
Lactosa/metabolismo , Levilactobacillus brevis/enzimología , beta-Galactosidasa/metabolismo , Medios de Cultivo , Fermentación , Glucosa/metabolismo , Ácido Láctico/metabolismo , Levilactobacillus brevis/crecimiento & desarrollo , Levilactobacillus brevis/metabolismo , Nitrofenilgalactósidos , Especificidad por Sustrato , beta-Galactosidasa/química , beta-Galactosidasa/genética , beta-Galactosidasa/aislamiento & purificación
7.
Altern Lab Anim ; 38(1): 11-27, 2010 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-20377301

RESUMEN

The Non-genotoxic Carcinogen Study Group in the Environmental Mutagen Society of Japan organised the second step of the inter-laboratory collaborative study on one-stage and two-stage cell transformation assays employing BALB/c 3T3 cells, with the objective of confirming whether the respective laboratories could independently produce results relevant to initiation or promotion. The method was modified to use a medium consisting of DMEM/F12 supplemented with 2% fetal bovine serum and a mixture of insulin, transferrin, ethanolamine and sodium selenite, at the stationary phase of cell growth. Seventeen laboratories collaborated in this study, and each chemical was tested by three to five laboratories. Comparison between the one-stage and two-stage assays revealed that the latter method would be beneficial in the screening of chemicals. In the test for initiating activity with the two-stage assay (post-treated with 0.1microg/ml 12-O-tetradecanoylphorbol-13-acetate), the relevant test laboratories all obtained positive results for benzo[a]pyrene and methylmethane sulphonate, and negative results for phenanthrene. Of those laboratories assigned phenacetin for the initiation phase, two returned positive results and two returned negative results, where the latter laboratories tested up to one dose lower than the maximum dose used by the former laboratories. In the exploration of promoting activity with the twostage assay (pretreated with 0.2microg/ml 3-methylcholanthrene), the relevant test laboratories obtained positive results for mezerein, sodium orthovanadate and TGF-beta1, and negative results for anthralin, phenacetin and phorbol. Two results returned for phorbol 12,13-didecanoate were positive, but one result was negative - again, the maximum dose to achieve the latter result was lower than that which produced the former results. These results suggest that this modified assay method is relevant, reproducible and transferable, provided that dosing issues, such as the determination of the maximum dose, are adequately considered. The application of this two-stage assay for screening the initiating and promoting potential of chemicals is recommended for consideration by other research groups and regulatory authorities.


Asunto(s)
Pruebas de Carcinogenicidad/métodos , Transformación Celular Neoplásica , Animales , Células 3T3 BALB , Conducta Cooperativa , Japón , Ratones
8.
Physiol Genomics ; 37(2): 79-87, 2009 Apr 10.
Artículo en Inglés | MEDLINE | ID: mdl-19106182

RESUMEN

To elucidate the physiological responses to a social stressor, we exposed mice to an isolation stress and analyzed their hepatic gene expression profiles using a DNA microarray. Male BALB/c mice were exposed to isolation stress for 30 days, and then hepatic RNA was sampled and subjected to DNA microarray analysis. The isolation stress altered the expression of 420 genes (after considering the false discovery rate). Gene Ontology analysis of these differentially expressed genes indicated that the stress remarkably downregulated the lipid metabolism-related pathway through peroxisome proliferator-activated receptor-alpha, while the lipid biosynthesis pathway controlled by sterol regulatory element binding factor 1, Golgi vesicle transport, and secretory pathway-related genes were significantly upregulated. These results suggest that isolation for 30 days with a mild and consecutive social stress regulates the systems for lipid metabolism and also causes endoplasmic reticulum stress in mouse liver.


Asunto(s)
Perfilación de la Expresión Génica , Metabolismo de los Lípidos/genética , Hígado/metabolismo , Aislamiento Social/psicología , Estrés Psicológico/fisiopatología , Animales , Análisis por Conglomerados , Masculino , Ratones , Ratones Endogámicos BALB C , Análisis de Secuencia por Matrices de Oligonucleótidos , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
9.
J Food Prot ; 72(9): 1923-9, 2009 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19777895

RESUMEN

Our purpose was to investigate the safety of the probiotic strain Lactobacillus brevis KB290. The European Qualified Presumption of Safety (QPS) evaluation approach was applied to the strain. We determined the strain's antibiotic resistance, verified it at the genetic level, and determined whether it could be transferred to intestinal microflora. Of 14 antibiotics tested, 11 showed MICs within the limits of the QPS criteria. However, the L. brevis KB290 MICs of ciprofloxacin (a fluoroquinolone), tetracycline, and vancomycin were two, four, and eight times, respectively, the breakpoint MICs suggested by the European Scientific Committee on Animal Nutrition, and the MIC of tetracycline was eight times the breakpoint MIC suggested by the European Scientific Panel on Additives and Products or Substances Used in Animal Feed. Using analysis of gapped-genome sequences, we found no known transferable determinants for tetracycline or vancomycin resistance, and we found no mutations in the quinolone resistance-determining regions of the genes encoding GyrA or ParC for ciprofloxacin resistance associated with insertion sequences, integrons, or transposons. These data were confirmed by using PCR primers specific for the respective genes. We assessed the transferability of the resistance traits in conjugation experiments with enterococci and obtained no transconjugants, strongly suggesting that the resistance traits were not transferable. This study demonstrated that the antibiotic resistance observed in L. brevis KB290 was due not to dedicated mechanisms but to intrinsic resistance. According to the QPS criteria, these results provide safety assurance for the ongoing use of L. brevis KB290 as a probiotic.


Asunto(s)
Antibacterianos/farmacología , Seguridad de Productos para el Consumidor , Farmacorresistencia Bacteriana/genética , Levilactobacillus brevis/efectos de los fármacos , Probióticos , Secuencia de Aminoácidos , Animales , Recuento de Colonia Microbiana , Conjugación Genética , Relación Dosis-Respuesta a Droga , Farmacorresistencia Bacteriana Múltiple , Humanos , Levilactobacillus brevis/genética , Pruebas de Sensibilidad Microbiana , Datos de Secuencia Molecular , Alineación de Secuencia
10.
J Biosci Bioeng ; 128(4): 391-397, 2019 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-31126721

RESUMEN

We demonstrate here that exopolysaccharide (EPS) production, cell aggregation, and bile resistance in Lactobacillus brevis KB290 are conferred by three eps genes (gtf27, gtf28, and orf29) located on the 42.4-kb plasmid pKB290-1. The predicted products of gtf27 and gtf28 belong to the membrane-bound glycosyltransferase family whereas the orf29 gene product showed homology with the ABC transporter. On in silico analysis, these genes were found to be widely distributed among lactobacilli from publicly available genomes and metagenomes, and their function is not yet elucidated. RT-PCR analysis showed that the eps genes were organised in an operon and their expression was markedly lower in arabinose- and xylose-containing media than in a glucose-containing medium. The three eps genes were cloned and expressed in homologous and heterologous strains. Considerably less EPS was produced by the plasmid-cured KB1802 strain than by the parental KB290 strain, whereas a similar amount was produced by the KB1802 strain expressing the three eps genes. The KB1802 strain expressing gtf27 and gtf28 but not orf29 did not produce EPS. Cell aggregation and bile resistance were also decreased in KB1802 strains but were complemented by eps genes. Moreover, the three eps genes conferred these phenotypes to a Lactobacillus plantarum strain. In conclusion, the three eps genes in pKB290-1 were sufficient for EPS biosynthesis with glucose and N-acetylglucosamine, and were responsible for cell aggregation and bile resistance. We consider these phenotypes to be at least partly responsible for KB290-specific properties.


Asunto(s)
Glicosiltransferasas/metabolismo , Levilactobacillus brevis/enzimología , Polisacáridos Bacterianos/biosíntesis , Ácidos y Sales Biliares/farmacología , Glicosiltransferasas/genética , Levilactobacillus brevis/efectos de los fármacos , Levilactobacillus brevis/genética , Lactobacillus plantarum/efectos de los fármacos , Lactobacillus plantarum/enzimología , Lactobacillus plantarum/genética , Operón , Plásmidos/genética , Probióticos
11.
Inflamm Bowel Dis ; 24(2): 317-331, 2018 01 18.
Artículo en Inglés | MEDLINE | ID: mdl-29361084

RESUMEN

Background: The ratio of colonic anti-inflammatory CD11c+ macrophages (MPs) to inflammatory CD103- dendritic cells (DCs) plays pivotal roles in intestinal inflammation. Little is known about how the ratio is regulated by lactic acid bacteria (LAB) and bifidobacteria (Bif). We investigated the contribution of LAB/Bif to this ratio. Methods: We established an in vitro experimental system using human myeloblastic KG-1 cells, which differentiate into CD11c+ MP-like (CD11c+ MPL) and CD103- DC-like (CD103- DCL) cells, and explored effective LAB/Bif strains. The selected strain's effect on the colonic CD11c+ MP/CD103- DC ratio and intestinal inflammation was examined in mice, and the strain's underlying mechanisms were investigated in vitro. Results: We screened 19 strains of LAB/Bif, and found that Lactobacillus brevis KB290 (KB290) increased the CD11c+ MPL/CD103- DCL cell ratio only in the presence of a vitamin A (VA) metabolite, retinoic acid (RA). Supplementation of KB290 with VA increased the CD11c+ MP/CD103- DC ratio in healthy mouse and prevented the disruption of the ratio during colitis. Supplementation of KB290 with pro-VA (ß-carotene) also increased the ratio in healthy mouse and ameliorated the development of colitis. The ratio was increased by reduction of CD103- DCs (or CD103- DCL cells). Our in vitro data suggested that KB290 induced cell death in CD103- DCL cells in the presence of RA signaling. Conclusions: Supplementation of KB290 with VA increases the colonic CD11c+ MP/CD103- DC ratio associated with the amelioration of murine colitis, suggesting a possible way to control intestinal inflammation by LAB.


Asunto(s)
Colitis/terapia , Células Dendríticas/citología , Levilactobacillus brevis , Macrófagos/citología , Probióticos , Vitamina A/uso terapéutico , Animales , Antígenos CD/metabolismo , Antígeno CD11c/metabolismo , Colitis/metabolismo , Modelos Animales de Enfermedad , Humanos , Inflamación/metabolismo , Inflamación/prevención & control , Mediadores de Inflamación/metabolismo , Cadenas alfa de Integrinas/metabolismo , Mucosa Intestinal/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL
12.
World J Gastroenterol ; 21(35): 10091-103, 2015 Sep 21.
Artículo en Inglés | MEDLINE | ID: mdl-26401074

RESUMEN

AIM: To investigate the effects of broccoli sprout extract (BSEx) on liver gene expression and acute liver injury in the rat. METHODS: First, the effects of BSEx on liver gene expression were examined. Male rats were divided into two groups. The Control group was fed the AIN-76 diet, and the BSEx group was fed the AIN-76 diet containing BSEx. After a 10-d feeding period, rats were sacrificed and their livers were used for DNA microarray and real-time reverse transcription-polymerase chain reaction (RT-PCR) analyses. Next, the effects of BSEx on acute liver injury were examined. In experiments using acute liver injury models, 1000 mg/kg acetaminophen (APAP) or 350 mg/kg D-galactosamine (D-GalN) was used to induce injury. These male rats were divided into four groups: Control, BSEx, Inducer (APAP or D-GalN), and Inducer+BSEx. The feeding regimens were identical for the two analyses. Twenty-four hours following APAP administration via p.o. or D-GalN administration via i.p., rats were sacrificed to determine serum aspartate transaminase (AST) and alanine transaminase (ALT) levels, hepatic glutathione (GSH) and thiobarbituric acid-reactive substances accumulation and glutathione-S-transferase (GST) activity. RESULTS: Microarray and real-time RT-PCR analyses revealed that BSEx upregulated the expression of genes related to detoxification and glutathione synthesis in normal rat liver. The levels of AST (70.91 ± 15.74 IU/mL vs 5614.41 ± 1997.83 IU/mL, P < 0.05) and ALT (11.78 ± 2.08 IU/mL vs 1297.71 ± 447.33 IU/mL, P < 0.05) were significantly suppressed in the APAP + BSEx group compared with the APAP group. The level of GSH (2.61 ± 0.75 nmol/g tissue vs 1.66 ± 0.59 nmol/g tissue, P < 0.05) and liver GST activity (93.19 ± 16.55 U/g tissue vs 51.90 ± 16.85 U/g tissue, P < 0.05) were significantly increased in the APAP + BSEx group compared with the APAP group. AST (4820.05 ± 3094.93 IU/mL vs 12465.63 ± 3223.97 IU/mL, P < 0.05) and ALT (1808.95 ± 1014.04 IU/mL vs 3936.46 ± 777.52 IU/mL, P < 0.05) levels were significantly suppressed in the D-GalN + BSEx group compared with the D-GalN group, but the levels of AST and ALT in the D-GalN + BSEx group were higher than those in the APAP + BSEx group. The level of GST activity was significantly increased in the D-GalN + BSEx group compared with the D-GalN group (98.04 ± 15.75 U/g tissue vs 53.15 ± 8.14 U/g tissue, P < 0.05). CONCLUSION: We demonstrated that BSEx protected the liver from various types of xenobiotic substances through induction of detoxification enzymes and glutathione synthesis.


Asunto(s)
Brassica/química , Enfermedad Hepática Inducida por Sustancias y Drogas/prevención & control , Regulación de la Expresión Génica/efectos de los fármacos , Hígado/efectos de los fármacos , Extractos Vegetales/farmacología , Sustancias Protectoras/farmacología , Acetaminofén , Animales , Biomarcadores/sangre , Enfermedad Hepática Inducida por Sustancias y Drogas/sangre , Enfermedad Hepática Inducida por Sustancias y Drogas/genética , Enfermedad Hepática Inducida por Sustancias y Drogas/patología , Citoprotección , Modelos Animales de Enfermedad , Galactosamina , Perfilación de la Expresión Génica/métodos , Glutatión/metabolismo , Inactivación Metabólica/efectos de los fármacos , Inactivación Metabólica/genética , Hígado/metabolismo , Hígado/patología , Masculino , Análisis de Secuencia por Matrices de Oligonucleótidos , Fitoterapia , Extractos Vegetales/aislamiento & purificación , Plantas Medicinales , Sustancias Protectoras/aislamiento & purificación , Ratas Wistar , Reacción en Cadena en Tiempo Real de la Polimerasa , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Plantones , Factores de Tiempo
13.
Mutat Res ; 540(2): 141-51, 2003 Oct 07.
Artículo en Inglés | MEDLINE | ID: mdl-14550498

RESUMEN

Transgenic rodent gene-mutation models provide relatively quick and statistically reliable assays for gene mutations in the DNA from any tissue. This report summarizes those issues that have been agreed upon at a previous IWGT meeting [Environ. Mol. Mutagen. 35 (2000) 253], and discusses in depth those issues for which no consensus was reached before. It was previously agreed that for regulatory applications, assays should be based upon neutral genes, be generally available in several laboratories, and be readily transferable. For phage-based assays, five to ten animals per group should be analyzed, assuming a spontaneous mutant frequency (MF) of approximately 3x10(-5) mutants/locus and 125,000-300,000 plaque or colony forming units (pfu or cfu) per tissue per animal. A full set of data should be generated for a vehicle control and two dose groups. Concurrent positive control animals are only necessary during validation, but positive control DNA must be included in each plating. Tissues should be processed and analyzed in a blocked design, where samples from negative control, positive control and each treatment group are processed together. The total number of pfus or cfus and the MF for each tissue and animal are reported. Statistical tests should consider the animal as the experimental unit. Nonparametric statistical tests are recommended. A positive result is a statistically significant dose-response and/or statistically significant increase in any dose group compared to concurrent negative controls using an appropriate statistical model. A negative result is a statistically non-significant change, with all mean MFs within two standard deviations of the control. During the current workshop, a general protocol was agreed in which animals are treated daily for 28 consecutive days and tissues sampled 3 days after the final treatment. This recommendation could be modified by reducing or increasing the number of treatments or the length of the treatment period, when scientifically justified. Normally male animals alone are sufficient and normally at least one rapidly proliferating and one slowly proliferating tissue should be sampled. Although, as agreed previously, sequencing data are not normally required, they might provide useful additional information in specific circumstances, mainly to identify and correct for clonal expansion and in some cases to determine a mechanism associated with a positive response.


Asunto(s)
Bioensayo/normas , Análisis Mutacional de ADN/normas , Animales , Animales Modificados Genéticamente , Femenino , Masculino , Ratones , Ratones Transgénicos , Ratas
14.
PLoS One ; 8(3): e60521, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23544154

RESUMEN

We determined the complete genome sequence of Lactobacillus brevis KB290, a probiotic lactic acid bacterium isolated from a traditional Japanese fermented vegetable. The genome contained a 2,395,134-bp chromosome that housed 2,391 protein-coding genes and nine plasmids that together accounted for 191 protein-coding genes. KB290 contained no virulence factor genes, and several genes related to presumptive cell wall-associated polysaccharide biosynthesis and the stress response were present in L. brevis KB290 but not in the closely related L. brevis ATCC 367. Plasmid-curing experiments revealed that the presence of plasmid pKB290-1 was essential for the strain's gastrointestinal tract tolerance and tendency to aggregate. Using next-generation deep sequencing of current and 18-year-old stock strains to detect low frequency variants, we evaluated genome stability. Deep sequencing of four periodic KB290 culture stocks with more than 1,000-fold coverage revealed 3 mutation sites and 37 minority variation sites, indicating long-term stability and providing a useful method for assessing the stability of industrial bacteria at the nucleotide level.


Asunto(s)
Genoma Bacteriano/genética , Inestabilidad Genómica/genética , Secuenciación de Nucleótidos de Alto Rendimiento/métodos , Levilactobacillus brevis/genética , Plásmidos/genética , Probióticos/metabolismo , Proteínas Bacterianas/metabolismo , Mapeo Cromosómico , Cromosomas Bacterianos/genética , Conjugación Genética/genética , ADN Circular/genética , Mutación/genética , Estrés Fisiológico/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA